The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.